Doctor profile · Federal record
Dr. Sophie Balzora, M.D.
Gastroenterology Physician (CMS: Gastroenterology) · New York, NY
- NPI 1487813994
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 20 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
355 W 52Nd St, 6Th Floor
New York, NY 100196239
(646) 754-2100
fax (646) 754-2151
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- February 23, 2021
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- New York #249923
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1487813994. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
190
Distinct HCPCS
6
Medicare allowed
$44,861
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 58 | 48 | $103 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 39 | 38 | $290 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 32 | 32 | $126 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 28 | 27 | $540 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | 16 | $345 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 15 | 13 | $147 |
In context: peer comparison
Among 165 peers in this city , average services per provider: 69. This provider delivers 2.8× the peer median.Open Payments
Industry payments received
All-time total
$40,020
Transactions
35
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 8 | $24,193.19 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $10,025.32 | |
| Janssen Biotech, Inc. | 7 | $5,184.26 | |
| ABBVIE INC. | 8 | $327.79 | |
| Janssen Research & Development, LLC | 1 | $122.38 | |
| Lilly USA, LLC | 2 | $59.61 | |
| Celltrion USA Inc. | 2 | $59.21 | |
| Celgene Corporation | 1 | $29.17 | |
| Boston Scientific Corporation | 1 | $19.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
160
Patients
77
Total drug cost
$21,543
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Omeprazole | Generic | 57 | 29 | $746 |
| Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl) | Brand | 50 | 48 | $793 |
| Mesalamine | Generic | 17 | 0 | $17,458 |
| Dexlansoprazole Dr (Dexlansoprazole) | Brand | 12 | 0 | $1,907 |
| Famotidine | Generic | 12 | 0 | $447 |
| Pantoprazole Sodium | Generic | 12 | 0 | $192 |
Hospital affiliations
Frequently asked questions
What is Dr. Sophie Balzora's medical specialty?
Dr. Sophie Balzora practices Gastroenterology Physician in New York, NY.
Where does Dr. Sophie Balzora practice?
Dr. Sophie Balzora practices at 355 W 52Nd St, New York, NY 100196239. Office phone: 6467542100.
What is Dr. Sophie Balzora's NPI?
Dr. Sophie Balzora's National Provider Identifier (NPI) is 1487813994, issued by NPPES.
Does Dr. Sophie Balzora accept Medicare assignment?
Yes. Dr. Sophie Balzora accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sophie Balzora commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Biopsy of large bowel using a flexible endoscope (HCPCS 45380); New patient office or other outpatient visit (HCPCS 99203). Source: CMS Medicare Physician & Other Practitioners file.